Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3291
Selected: 0
NCT IDTitle
NCT00525031Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
NCT06683755Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
NCT07038915STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
NCT00499421Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
NCT04971187Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
NCT06651593Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
NCT04817709Development of a Patient Decision Aid for Women Considering Breast Reconstruction
NCT00840749Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
NCT05900648Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
NCT05497024Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
NCT03656224Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With Cancer
NCT02269280Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
NCT00936117Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
NCT01409174IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
NCT056743963-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
NCT03283046Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
NCT005046606-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
NCT03592459Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer
NCT04310397Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
NCT04186884Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings
NCT00761618Intrapleural Catheter Daily Versus Three Times a Week Drainage
NCT01938716Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
NCT00880815Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
NCT02199184Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT03743649Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
NCT00449748Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
NCT01504126Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT04837716Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
NCT00642317Asian Youth and Tobacco Control Survey
NCT00745732Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)
NCT00866749Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
NCT01213238Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
NCT03784326Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma
NCT01370278Clearance Of Mucus In Stents (COMIS)
NCT07325253A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
NCT07283653Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
NCT05007873ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
NCT01392170Pegasys in Patients With Chronic Myeloid Leukemia (CML)
NCT04189770Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
NCT02282969PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
NCT03390283A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer Center
NCT06083857PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
NCT03911388HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
NCT02521194Occupational Therapy in Palliative Care
NCT05681039Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
NCT06295783Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
NCT01728545The Collection and Storage of Umbilical Cord Blood for Transplantation
NCT00512096Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
NCT00503256Genetic Study of Chronic Lymphocytic Leukemia Families
NCT05726383Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma